Regeneron Pharmaceuticals Inc. sell robertinio
Start price
20.04.20
/
50%
€534.90
Target price
01.05.20
-
Performance (%)
-9.33%
End price
01.05.20
€485.00
Summary
This prediction ended on 01.05.20 with a price of €485.00. With a performance of -9.33%, the SELL prediction for Regeneron Pharmaceuticals Inc. by robertinio was down slightly. robertinio has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 4.817% | 4.817% | -3.086% | -2.831% |
| iShares Core DAX® | 0.765% | 4.791% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 1.418% | 3.133% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.658% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 1.310% | 2.279% | 3.125% | 68.687% |
Comments by robertinio for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Sell Regeneron Pharmaceuticals Inc.